Poxel
Research integrated pharmaceutical company that develops products for metabolic diseases.
Launch date
Employees
Market cap
CAD43.9m
Enterprise valuation
CAD101m (Public information from Sep 2024)
Share price
€0.554 POXEL.PA
Company register number 510970817
Lyon Auvergne-Rhône-Alpes (HQ)
Authorizing premium user...